(Q40419995)

20 September 2017

1 reference

title

Detection of latent prostate cancer from routine screening: comparison with breast cancer screening (English)

1 reference

20 September 2017

breast cancer screening

1 reference

Benoit RM

1

1 reference

PubMed ID

7571223

20 September 2017

Naslund MJ

series ordinal

2

1 reference

PubMed ID

7571223

20 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

20 September 2017

1 reference

20 September 2017

46

1 reference

20 September 2017

533-6; discussion 536-7

1 reference

20 September 2017

4

1 reference

Routine screening for cancer of the prostate

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Questioning the value of screening for prostate cancer in asymptomatic men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Prostate cancer screening: current trends and future implications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

United States Preventive Services Task Force recommendations on breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

An economic rationale for prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Latent carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Latent prostatic cancer in a consecutive autopsy series

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Probabilities of eventually developing or dying of cancer--United States, 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

On the diagnosis and treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Do screening-detected invasive breast cancers have a natural history of their own?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

In situ carcinomas of the female breast. Incidence, clinical findings and DBCG proposals for management

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

In situ intraduct carcinoma of the breast: A long term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Treatment and survival of female patients with nonpalpable breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Management of screen detected ductal carcinoma in situ of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Positive predictive value of screening mammography by age and family history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Breast Cancer Detection Demonstration Project: five-year summary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

Future studies in localized prostate cancer. What should we think? What can we do?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980267-2

7 January 2021

10.1016/S0090-4295(99)80267-2

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7571223